264 related articles for article (PubMed ID: 25678491)
1. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R
J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491
[TBL] [Abstract][Full Text] [Related]
2. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
Oprea-Lager DE; Kramer G; van de Ven PM; van den Eertwegh AJ; van Moorselaar RJ; Schober P; Hoekstra OS; Lammertsma AA; Boellaard R
J Nucl Med; 2016 May; 57(5):721-7. PubMed ID: 26697964
[TBL] [Abstract][Full Text] [Related]
3. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Simplified Methods for Quantification of
Kramer GM; Yaqub M; Vargas HA; Schuit RC; Windhorst AD; van den Eertwegh AJM; van der Veldt AAM; Bergman AM; Burnazi EM; Lewis JS; Chua S; Staton KD; Beattie BJ; Humm JL; Davis ID; Weickhardt AJ; Scott AM; Morris MJ; Hoekstra OS; Lammertsma AA
J Nucl Med; 2019 Sep; 60(9):1221-1227. PubMed ID: 30850488
[No Abstract] [Full Text] [Related]
5. Simplified Methods for Quantification of
Jansen BHE; Yaqub M; Voortman J; Cysouw MCF; Windhorst AD; Schuit RC; Kramer GM; van den Eertwegh AJM; Schwarte LA; Hendrikse NH; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
J Nucl Med; 2019 Dec; 60(12):1730-1735. PubMed ID: 31000583
[TBL] [Abstract][Full Text] [Related]
6. [18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
Poulsen MH; Bouchelouche K; Gerke O; Petersen H; Svolgaard B; Marcussen N; Svolgaard N; Ogren M; Vach W; Høilund-Carlsen PF; Geertsen U; Walter S
BJU Int; 2010 Sep; 106(5):639-43; discussion 644. PubMed ID: 20089104
[TBL] [Abstract][Full Text] [Related]
7. Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer.
Oprea-Lager DE; Vincent AD; van Moorselaar RJ; Gerritsen WR; van den Eertwegh AJ; Eriksson J; Boellaard R; Hoekstra OS
PLoS One; 2012; 7(10):e48430. PubMed ID: 23119014
[TBL] [Abstract][Full Text] [Related]
8. Full kinetic modeling analysis of [
Rubí S; Bibiloni P; Villar M; Brell M; Valiente M; Galmés M; Toscano M; Matheu G; Chinchilla JL; Molina J; Luis Valera J; Ríos Á; López M; Peña C
Neuroimage Clin; 2024; 42():103616. PubMed ID: 38763039
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modeling of
Ringheim A; Campos Neto GC; Anazodo U; Cui L; da Cunha ML; Vitor T; Martins KM; Miranda ACC; de Barboza MF; Fuscaldi LL; Lemos GC; Colombo Junior JR; Baroni RH
EJNMMI Res; 2020 Feb; 10(1):12. PubMed ID: 32140850
[TBL] [Abstract][Full Text] [Related]
10. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of [
Cysouw M; Bouman-Wammes E; Hoekstra O; van den Eertwegh A; Piet M; van Moorselaar J; Boellaard R; Dahele M; Oprea-Lager D
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):406-410. PubMed ID: 29559285
[TBL] [Abstract][Full Text] [Related]
12. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.
Verwer EE; van Velden FH; Bahce I; Yaqub M; Schuit RC; Windhorst AD; Raijmakers P; Lammertsma AA; Smit EF; Boellaard R
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1523-31. PubMed ID: 23740374
[TBL] [Abstract][Full Text] [Related]
14. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
[TBL] [Abstract][Full Text] [Related]
15. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W
Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
[TBL] [Abstract][Full Text] [Related]
16. Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients.
Verwer EE; Bahce I; van Velden FH; Yaqub M; Schuit RC; Windhorst AD; Raijmakers P; Hoekstra OS; Lammertsma AA; Smit EF; Boellaard R
J Nucl Med; 2014 Nov; 55(11):1772-7. PubMed ID: 25324522
[TBL] [Abstract][Full Text] [Related]
17. Quantitative
Schaefferkoetter JD; Wang Z; Stephenson MC; Roy S; Conti M; Eriksson L; Townsend DW; Thamboo T; Chiong E
EJNMMI Res; 2017 Dec; 7(1):25. PubMed ID: 28324340
[TBL] [Abstract][Full Text] [Related]
18. Determining the optimal pharmacokinetic modelling and simplified quantification method of [
Zhao R; Xia Z; Ke M; Lv J; Zhong H; He Y; Gu D; Liu Y; Zeng G; Zhu L; Alexoff D; Kung HF; Wang X; Sun T
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2124-2133. PubMed ID: 38285206
[TBL] [Abstract][Full Text] [Related]
19. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
[TBL] [Abstract][Full Text] [Related]
20. Quantification of PD-L1 Expression with
Huisman MC; Niemeijer AN; Windhorst AD; Schuit RC; Leung D; Hayes W; Poot A; Bahce I; Radonic T; Oprea-Lager DE; Hoekstra OS; Thunnissen E; Hendrikse NH; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2020 Oct; 61(10):1455-1460. PubMed ID: 32060213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
